Global biologics spending 2002-2017
This statistic shows total global spending on biologics in 2002, 2007 and 2012, with a projection for 2017. In 2002, expenditure on biosimilars was 46 billion U.S. dollars.
Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Biologics share of global pharmaceutical spending 2002-2017
- Global medicines spending share by product type forecast 2023
- Global medicine spending by region and type 2014
- Average cost of medical prescriptions in pharmacies in Spain 2010-2016
- Expenditure for self-medication products in Italy 2013-2018
- GDP expenditure on pharmaceuticals and medical non-durables in Germany 2005-2015
- GDP expenditure on pharmaceuticals and other medical non-durables in Cyprus 2005-2015
- Market size of branded biopharmaceuticals in China 2013-2022
- GDP expenditure on pharmaceuticals and medical non-durables in Sweden 2003-2013
- GDP expenditure on pharmaceuticals and other medical non-durables in Romania 2005-15
- Share of GDP expenditure on pharmaceuticals in Italy 1990-2017
- GDP expenditure on pharmaceuticals and other medical non-durables in France 2003-2013
- GDP expenditure on pharmaceuticals and medical non-durables in Austria 2005-2015
- GDP expenditure on pharmaceuticals and medical non-durables in Malta 2005-2014
- NHS expenditure per prescription dispensed in pharmacies in Spain 2015, by region
- Italy: estimated market value of biosimilars 2018-2022, by type
- Global exports of pharmaceuticals in selected countries 2012
- Italy: market value of biopharmaceuticals 2017, by type
- Italy: market share of biosimilars 2017, by molecule
- Total biopharmaceutical revenue worldwide 2006-2011
IMS Health. (November 15, 2013). Total global biologics spending from 2002 and 2017 (in billion U.S. dollars) [Graph]. In Statista. Retrieved February 22, 2020, from https://www.statista.com/statistics/280578/global-biologics-spending/
IMS Health. "Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)." Chart. November 15, 2013. Statista. Accessed February 22, 2020. https://www.statista.com/statistics/280578/global-biologics-spending/
IMS Health. (2013). Total global biologics spending from 2002 and 2017 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: February 22, 2020. https://www.statista.com/statistics/280578/global-biologics-spending/
IMS Health. "Total Global Biologics Spending from 2002 and 2017 (in Billion U.S. Dollars)." Statista, Statista Inc., 15 Nov 2013, https://www.statista.com/statistics/280578/global-biologics-spending/
IMS Health, Total global biologics spending from 2002 and 2017 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/280578/global-biologics-spending/ (last visited February 22, 2020)